|
Polymorphisms
|
Adjusted OR for age and gender (95% CI)/p
|
|---|
|
Tumor size (≥5 cm)
|
Differentiated status (poorly)
|
Clinical stage (III-IV)
|
Metastasis (yes)
|
|---|
|
rs1016343C/T
|
0.82(0.59-1.13)/0.22
|
1.05(0.72-1.55)/0.79
|
1.07(0.77-1.49)/0.70
|
1.27(0.91-1.78)/0.16
|
|
rs13252298A/G
|
1.07(0.75-1.52)/0.72
|
1.21(0.80-1.82)/0.37
|
0.85(0.59-1.21)/0.36
|
0.76(0.53-1.10)/0.15
|
|
rs7007694T/C
|
0.74(0.51-1.08)/0.11
|
0.46(0.28-0.77)/0.003
|
1.04(0.71-1.51)/0.85
|
1.11(0.76-1.62)/0.59
|
|
rs16901946A/G
|
0.84(0.59-1.22)/0.36
|
0.59(0.37-0.94)/0.03
|
1.09(0.76-1.58)/0.64
|
1.26(0.87-1.83)/0.22
|
|
rs1456315A/G
|
1.56(1.10-2.23)/0.01
|
1.54(1.03-2.31)/0.04
|
1.16(0.81-1.66)/0.43
|
1.06(0.73-1.52)/0.77
|
- CRC: colorectal cancer; OR: odds ratio; CI: confidence interval.
- The smaller size, well differentiated status, clinical stage I-II, and the ones without metastasis were made as references, respectively.
